Helius and U.S. Army Extend Sole Source Contract for PoNS Device Testing and Development

Helius has executed an extension and amendment to the sole source cost sharing contract entered into with the U.S. Army Medical Research and Material Command to include additional study sites for the portable neuromodulation stimulator (PoNS) clinical trial.

The PoNS is being studied in the U.S. and Canada for the treatment of neurological symptoms caused by disease or trauma.

The contract is extended to December 31, 2017. — Cynthia Jessup